Cargando…
Claudin-9 is a novel prognostic biomarker for endometrial cancer
The tight-junction protein claudin-9 (CLDN9) is barely distributed in normal adult tissues but is ectopically expressed in various cancer types. Although multiple databases indicated upregulation of CLDN9 in endometrial cancers at the mRNA level, its protein expression and biological roles remain ob...
Autores principales: | Endo, Yuta, Sugimoto, Kotaro, Kobayashi, Makoto, Kobayashi, Yasuyuki, Kojima, Manabu, Furukawa, Shigenori, Soeda, Shu, Watanabe, Takafumi, Higashi, Atsuko Y., Higashi, Tomohito, Hashimoto, Yuko, Fujimori, Keiya, Chiba, Hideki |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9521636/ https://www.ncbi.nlm.nih.gov/pubmed/36129146 http://dx.doi.org/10.3892/ijo.2022.5425 |
Ejemplares similares
-
Reduced Claudin-12 Expression Predicts Poor Prognosis in Cervical Cancer
por: Rahman, Abidur, et al.
Publicado: (2021) -
Prognostic Significance of Aberrant Claudin-6 Expression in Endometrial Cancer
por: Kojima, Manabu, et al.
Publicado: (2020) -
Addendum: Manabu, K., et al. Prognostic Significance of Aberrant Claudin-6 Expression in Endometrial Cancer. Cancers 2020, 12, 2748
por: Kojima, Manabu, et al.
Publicado: (2021) -
SPON1 is an independent prognostic biomarker for ovarian cancer
por: Miyakawa, Ryoya, et al.
Publicado: (2023) -
Prediction of lymphovascular space invasion in endometrial cancer using the 55-gene signature selected by DNA microarray analysis
por: Watanabe, Takafumi, et al.
Publicado: (2019)